share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 4 01:41
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.